NCT06171906View on ClinicalTrials.gov

Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation

PHASE4Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

October 1, 2025

Study Completion Date

November 1, 2028

Conditions

MSC

Interventions

BIOLOGICAL

mesenchymal stromal cells

On the basis of conventional PGF treatment for poor implantation, the enrolled patients were injected with 1×10\^6/kg mesenchymal stem cells of cord blood weekly for 4 consecutive weeks

Trial Locations (2)

410000

Xinqiao Hospital, Chongqing

Unknown

Second Affiliated Hospital, Army Medical University, PLA, Chongqing

All Listed Sponsors

collaborator

Xinqiao Hospital of Chongqing

OTHER

lead

ShiCang Yu

OTHER